DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,397,421 | -34.1% | 2,311,118 | -27.1% | 0.00% | 0.0% |
| Q2 2023 | $44,626,490 | -13.1% | 3,169,495 | -4.6% | 0.00% | -33.3% |
| Q1 2023 | $51,327,218 | -54.6% | 3,322,150 | -51.8% | 0.00% | 0.0% |
| Q4 2022 | $113,026,226 | +89.8% | 6,896,048 | +114.2% | 0.00% | -25.0% |
| Q3 2022 | $59,558,000 | +15.2% | 3,219,331 | -18.1% | 0.00% | +33.3% |
| Q2 2022 | $51,692,000 | -2.8% | 3,930,917 | -31.5% | 0.00% | 0.0% |
| Q1 2022 | $53,198,000 | -16.0% | 5,738,770 | -11.4% | 0.00% | 0.0% |
| Q4 2021 | $63,298,000 | -3.0% | 6,478,822 | +237.3% | 0.00% | 0.0% |
| Q3 2021 | $65,273,000 | -13.1% | 1,920,920 | -6.3% | 0.00% | -25.0% |
| Q2 2021 | $75,081,000 | -9.9% | 2,050,834 | +10.3% | 0.00% | -20.0% |
| Q1 2021 | $83,359,000 | -20.4% | 1,859,037 | +1.4% | 0.01% | -16.7% |
| Q4 2020 | $104,671,000 | +15.3% | 1,834,075 | +3.7% | 0.01% | 0.0% |
| Q3 2020 | $90,758,000 | -11.7% | 1,769,162 | +2.8% | 0.01% | -14.3% |
| Q2 2020 | $102,757,000 | +133.0% | 1,720,638 | +60.6% | 0.01% | +75.0% |
| Q1 2020 | $44,109,000 | -31.5% | 1,071,387 | +3.5% | 0.00% | 0.0% |
| Q4 2019 | $64,434,000 | +151.7% | 1,035,244 | +37.3% | 0.00% | +100.0% |
| Q3 2019 | $25,599,000 | +80.1% | 754,236 | +19.7% | 0.00% | +100.0% |
| Q2 2019 | $14,212,000 | -1.7% | 630,231 | +1.2% | 0.00% | 0.0% |
| Q1 2019 | $14,451,000 | +16.9% | 622,621 | +5.7% | 0.00% | 0.0% |
| Q4 2018 | $12,366,000 | -45.5% | 589,153 | +0.5% | 0.00% | -50.0% |
| Q3 2018 | $22,689,000 | +291.3% | 585,960 | +297.7% | 0.00% | – |
| Q2 2018 | $5,798,000 | +133.9% | 147,330 | +19.1% | 0.00% | – |
| Q1 2018 | $2,479,000 | +59.1% | 123,741 | +80.2% | 0.00% | – |
| Q4 2017 | $1,558,000 | – | 68,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |